Abstract
The Oncofactory startup's mission is to accelerate the development of precision medicine and personalized treatment in oncology. It operates a technological platform designed by a fundamental research team specializing in the development of the nervous system. This platform was born out of a desire to transfer developmental biology expertise and technologies to the problem of pediatric and adult cancers. The platform focuses on an innovative animal model, the avian embryo. It enables the design of new tools for modeling and analyzing tumor heterogeneity in patients with the same type of cancer, for the development of targeted therapies and biomarkers predictive of their efficacy.
